We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCM icon
1926
Stellus Capital Investment Corp
SCM
$248M
$2.11M ﹤0.01%
177,071
-10,416
-6% -$135K
URTH icon
1927
iShares MSCI World ETF
URTH
$8.38B
$2.11M ﹤0.01%
21,078
-1,002
-5% -$111K
ELS icon
1928
Equity Lifestyle Properties
ELS
$12.7B
$2.1M ﹤0.01%
33,488
+4,066
+14% +$292K
LYG icon
1929
Lloyds Banking Group
LYG
$90.1B
$2.1M ﹤0.01%
1,175,533
-216,440
-16% -$449K
KRC icon
1930
Kilroy Realty
KRC
$4.25B
$2.1M ﹤0.01%
49,852
+618
+1% +$31.2K
ADSE icon
1931
ADS-TEC Energy
ADSE
$872M
$2.09M ﹤0.01%
280,784
+2,651
+1% +$20.2K
RMT
1932
Royce Micro-Cap Trust
RMT
$779M
$2.09M ﹤0.01%
263,278
+15,016
+6% +$133K
DKL icon
1933
Delek Logistics
DKL
$2.85B
$2.08M ﹤0.01%
40,849
-3,645
-8% -$198K
COIN icon
1934
Coinbase
COIN
$39.5B
$2.08M ﹤0.01%
32,257
-959
-3% -$67K
SCHA icon
1935
Schwab U.S Small- Cap ETF
SCHA
$23.6B
$2.08M ﹤0.01%
109,906
-77,150
-41% -$1.61M
ARMR
1936
DELISTED
Armor US Equity Index ETF
ARMR
$2.08M ﹤0.01%
105,426
-55,113
-34% -$1.21M
PNR icon
1937
Pentair
PNR
$10.5B
$2.07M ﹤0.01%
50,992
+623
+1% +$28.9K
BPMC
1938
DELISTED
Blueprint Medicines
BPMC
$2.07M ﹤0.01%
31,433
+2,551
+9% +$164K
LEAD
1939
DELISTED
Siren DIVCON Leaders Dividend ETF
LEAD
$2.07M ﹤0.01%
45,775
-500
-1% -$25.1K
FAD icon
1940
First Trust Multi Cap Growth AlphaDEX Fund
FAD
$600M
$2.06M ﹤0.01%
23,043
+25
+0.1% +$2.45K
CAC icon
1941
Camden National
CAC
$991M
$2.06M ﹤0.01%
48,462
+909
+2% +$41.3K
CQP icon
1942
Cheniere Energy
CQP
$33.2B
$2.06M ﹤0.01%
38,549
+5,891
+18% +$295K
GHYB icon
1943
Goldman Sachs Access High Yield Corporate Bond ETF
GHYB
$134M
$2.06M ﹤0.01%
50,700
+4,418
+10% +$190K
SII
1944
Sprott
SII
$3.01B
$2.06M ﹤0.01%
61,330
+3,503
+6% +$126K
HUBG icon
1945
HUB Group
HUBG
$2.47B
$2.04M ﹤0.01%
59,192
+3,534
+6% +$135K
QLYS icon
1946
Qualys
QLYS
$6.56B
$2.03M ﹤0.01%
14,586
+9,320
+177% +$1.31M
VIOG icon
1947
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.14B
$2.03M ﹤0.01%
23,164
+206
+0.9% +$19.9K
SPR
1948
DELISTED
Spirit AeroSystems
SPR
$2.02M ﹤0.01%
92,394
-4,876
-5% -$148K
JFR icon
1949
Nuveen Floating Rate Income Fund
JFR
$1.24B
$2.02M ﹤0.01%
248,930
+8,156
+3% +$70.1K
CRUS icon
1950
Cirrus Logic
CRUS
$6.05B
$2.02M ﹤0.01%
29,306
+4,659
+19% +$366K

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.